Framtiden Management Co. has announced its opposition to the proposed acquisition of Swedish Match by Philip Morris International. Framtiden Partnerships owns over 14.5 million shares, representing approximately 1% of the outstanding shares.
As a long-term shareholder of Swedish Match since 2003, Framtiden believes that the takeover offer of 106 Swedish Kronor per share significantly undervalues the company's worth. Framtiden estimates that the company is worth approximately 200 Swedish Kronor per share.
According to Framtiden, the offer did not adequately recognize Sweden's Match's leading position in the rapidly-growing nicotine pouch market and its global potential. Additionally, investors feel that the offer undervalues the uniqueness of Match's rapidly-growing, mature global consumer essential business and forces long-term investors who wish to participate in the company's continued growth to realize capital gains, otherwise these gains will be deferred.
In a statement, Dan Zhuran, a managing member of Framtiden Partnerships, said, "My partner, Chris Anderson, and I believe this deal is not in the interest of long-term shareholders. Over the past twenty years, I have closely followed the development of Swedish Match, established relationships with its managers, and currently serve as chairman of the company's nomination committee. I am disappointed to see the board recommend selling this Swedish gem at a low price during what could be its greatest chapter in history.
Zhulan stated that although investors may be tempted by short-term premiums, especially during market downturns, he compared the potential of Swedish Match to that of Coca-Cola in the 1980s and Philip Morris in the 1950s.
These companies have seen a compound growth rate over the years, resulting in lucrative returns for shareholders who have stayed the course," he said. "We believe that holding onto investments in Swedish Match over time could yield greater returns for shareholders than cashing out. We hope that other shareholders will see the advantages of our position, as further detailed in our white paper.
Framtiden Management Co., along with Elliott Management Corp. and Bronte Capital, have claimed that PMI's offer undervalues Swedish Match. It is believed that Elliott Management Corp. will increase its stake in Swedish Match in order to secure a better price from PMI.
PMI announced that its acquisition deal has received approval from regulatory agencies in Brazil and the United States. European regulatory agencies have stated that they intend to review the bid before October 11.
Statement:
This article is compiled based on third-party information and is intended only for industry-related exchange and education.
This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity and accuracy of the content. The translation of this article is only intended for industry-related communication and research.
Due to the limitations of our translation ability, the translated article may not fully express the same meaning as the original. Please refer to the original article for accuracy.
2FIRSTS maintains complete alignment with the Chinese government on any statements or positions related to domestic, Hong Kong, Macau, Taiwan, and foreign affairs.
The copyright of the compiled information belongs to the original media and authors. If there is any infringement, please contact us for deletion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
